Linear epitope landscape of SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
preprint
OA: gold
CC-BY-NC-ND-4.0
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (37)
- A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities via crossref
- Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic Analysis via crossref
- Global profiling of SARS-CoV-2 specific IgG/ IgM responses of convalescents using a proteome microarray via crossref
- Human IgG neutralizing monoclonal antibodies block SARS-CoV-2 infection via crossref
- Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients via crossref
- Map of SARS-CoV-2 spike epitopes not shielded by glycans via crossref
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability via crossref
- ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens via crossref
- SARS-CoV-2 proteome microarray for mapping COVID-19 antibody interactions at amino acid resolution via crossref
- Structural and functional analysis of a potent sarbecovirus neutralizing antibody via crossref
- The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity via crossref
- doi:10.1038/s41467-020-16638-2 via crossref
- doi:10.1172/jci.insight.123158 via crossref
- doi:10.1016/j.immuni.2020.05.002 via crossref
- doi:10.1016/0022-2836(82)90515-0 via crossref
- doi:10.1038/s41596-020-0358-9 via crossref
- doi:10.1038/s41591-020-0897-1 via crossref
- doi:10.1128/jvi.55.3.836-839.1985 via crossref
- doi:10.1126/sciimmunol.abc8413 via crossref
- doi:10.1038/s41422-020-0366-x via crossref
- doi:10.1038/s41586-020-2381-y via crossref
- doi:10.1038/s41586-020-2380-z via crossref
- doi:10.1016/j.it.2020.04.008 via crossref
- doi:10.1016/j.cell.2020.06.043 via crossref
- doi:10.1016/s0140-6736(04)15788-7 via crossref
- doi:10.1038/s41586-020-2012-7 via crossref
- doi:10.1016/j.ebiom.2020.102674 via crossref
- doi:10.1038/s41586-020-2008-3 via crossref
- doi:10.1016/s1473-3099(20)30120-1 via crossref
- doi:10.1038/s41591-020-0820-9 via crossref
- doi:10.1126/science.abb9983 via crossref
- doi:10.1126/science.abc2241 via crossref
- doi:10.1126/science.abb7269 via crossref
- doi:10.1126/science.abc7424 via crossref
- doi:10.1126/science.abd0831 via crossref
- doi:10.1126/science.abd0827 via crossref
- doi:10.1126/science.abc7520 via crossref
Source provenance
- crossref
- last seen: 2026-06-14T06:15:43.591097+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-21T02:00:01.467718+00:00
License: CC-BY-NC-ND-4.0